Regenerative Medical Technology Group Inc.
RMTG
$0.04
$0.007.24%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.18M | 983.50K | 1.36M | 1.51M | 986.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.18M | 983.50K | 1.36M | 1.51M | 986.30K |
| Cost of Revenue | 679.00K | 397.70K | 420.40K | 530.60K | 239.20K |
| Gross Profit | 501.60K | 585.80K | 943.90K | 980.20K | 747.10K |
| SG&A Expenses | 846.20K | 741.10K | 757.10K | 625.00K | 635.20K |
| Depreciation & Amortization | 76.10K | 54.80K | 51.80K | -27.80K | 88.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.60M | 1.19M | 1.23M | 1.13M | 963.30K |
| Operating Income | -420.80K | -210.10K | 135.00K | 383.00K | 23.10K |
| Income Before Tax | -4.35M | -1.31M | -760.00K | -638.20K | -887.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.35M | -1.31M | -760.00K | -638.20K | -887.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.35M | -1.31M | -760.00K | -638.20K | -887.10K |
| EBIT | -420.80K | -210.10K | 135.00K | 383.00K | 23.10K |
| EBITDA | -344.70K | -155.30K | 186.80K | 438.10K | 111.90K |
| EPS Basic | -0.35 | -0.10 | -0.06 | -0.05 | -0.07 |
| Normalized Basic EPS | -0.20 | -0.07 | -0.04 | -0.03 | -0.04 |
| EPS Diluted | -0.35 | -0.10 | -0.06 | -0.05 | -0.07 |
| Normalized Diluted EPS | -0.20 | -0.07 | -0.04 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 12.54M | 12.54M | 12.54M | 12.54M | 12.54M |
| Average Diluted Shares Outstanding | 12.54M | 12.54M | 12.54M | 12.54M | 12.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |